首页 | 本学科首页   官方微博 | 高级检索  
     

奥曲肽对重症急性胰腺炎患者血清炎性细胞因子的影响
引用本文:刘建新. 奥曲肽对重症急性胰腺炎患者血清炎性细胞因子的影响[J]. 中国实用医药, 2008, 3(36): 25-26
作者姓名:刘建新
作者单位:山东中医药大学第二附属医院药剂科,250001
摘    要:目的研究奥曲肽对重症急性胰腺炎(severe acute panereatitis,SAP)患者血清白细胞介素-6(interleukin6,IL-6)、白细胞介素-8(interleukin8,IL-8)及肿瘤坏死因子-α(tumornecrosisfactor-α,TNF-α)等细胞因子的影响。方法48例SAP患者随机分成丹参治疗组及非丹参治疗组,每组24例;选择年龄匹配的20例健康志愿者为对照组。在患者入院24h内以及治疗4、7d后采静脉血并检测血清中IL-6、IL-8和TNF-α水平。结果SAP患者3种炎症因子较健康志愿者均显著升高(P〈0.05)。奥曲肽治疗组与非奥曲肽治疗组入院时3种细胞因子差异无统计学意义(P〉0.05),治疗4、7d后两组SAP患者3种细胞因子均降低(P〈0.05),但奥曲肽治疗组下降更明显(P〈0.05)。结论奥曲肽可降低SAP患者的炎症性细胞因子。

关 键 词:奥曲肽  重症胰腺炎  白细胞介素-6  自细胞介素-8  肿瘤坏死因子-α

Effects of octreotide on serum levels of inflammatory cytokines in patient with severe acute pancreatitis
LIU Jian-xin. Effects of octreotide on serum levels of inflammatory cytokines in patient with severe acute pancreatitis[J]. China Practical Medical, 2008, 3(36): 25-26
Authors:LIU Jian-xin
Affiliation:LIU Jian-xin. Department of Pharmacy,Shandong Medical University of TCM.in Jinan City,Shandong 250031,China
Abstract:Objective To study the effects of octreotide on serum levels of cytokines including inter-leukin-6 (IL-6) ,interleukin-8 ( IL-8 ) and tumor necrosis factor alpha ( TNF-α ) in patients with severe acute pancreatitis(SAP). Methods Forty eight SAP patients were randomly divided into octreotide-treated group and non-octreotide treated group with twenty four patients in each group. Twenty age-matched healthy volunteers were assigned to control group. Serum levels of IL-6, IL-8 and TNF-α were tested within 24 hours of admission 4 days and 7 days after admission. Results Compared with those of the healthy volunteers, serum levels of the IL-6, IL-8 and TNF-α of the SAP patients were significantly elevated (P 〈 0. 01 ). Serum levels of the three cy- tokines were significantly decreased in both octreotide-treated group and nonoctreotide-treated group after 7-day treatment( P 〈 0. 05 ). The declining of the serum levels of the three cytokines in octreotide-treated group was more obvious than that in non-octreotide treated group. Conclusion Octreotide can treat SAP patients by reducing the serum levels of IL-6, IL-8, and TNF-α.
Keywords:Octreotide  Severe acute pancreatitis  Interleukin-6  Interleukin-8  Tumor necrosis factor alpha  
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号